Financial Counselors Inc Dexcom Inc Transaction History

Financial Counselors Inc

$6.67 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$110.31 - $140.45 $96,190 - $122,472	-872 Reduced 26.67%	2,398 $271,000
Q1 2024 May 02, 2024	SELL	$114.22 - $140.1 $79,040 - $96,949	-692 Reduced 17.47%	3,270 $453,000
Q4 2023 Jan 26, 2024	SELL	$75.49 - $124.16 $2.43 Million - $3.99 Million	-32,139 Reduced 89.03%	3,962 $491,000
Q3 2023 Nov 07, 2023	BUY	$86.06 - $137.93 $771,958 - $1.24 Million	8,970 Added 33.06%	36,101 $3.37 Million
Q2 2023 Jul 27, 2023	SELL	$112.47 - $130.98 $6,523 - $7,596	-58 Reduced 0.21%	27,131 $3.49 Million
Q1 2023 May 02, 2023	BUY	$104.0 - $122.92 $63,960 - $75,595	615 Added 2.31%	27,189 $3.16 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $2.04 Million - $2.95 Million	24,034 Added 946.22%	26,574 $3.01 Million
Q3 2022 Nov 01, 2022	BUY	$76.35 - $94.18 $193,929 - $239,217	2,540 New	2,540 $205,000
Q2 2022 Aug 02, 2022	SELL	$67.99 - $132.89 $42,493 - $83,056	-625 Closed	0 $0
Q1 2022 Apr 28, 2022	SELL	$94.08 - $130.2 $1,411 - $1,952	-15 Reduced 2.34%	625 $320,000
Q4 2021 Feb 10, 2022	SELL	$129.87 - $162.82 $14,935 - $18,724	-115 Reduced 15.23%	640 $344,000
Q3 2021 Oct 26, 2021	SELL	$106.71 - $143.18 $4,801 - $6,443	-45 Reduced 5.63%	755 $413,000
Q1 2021 Apr 29, 2021	SELL	$84.79 - $104.74 $6,528 - $8,064	-77 Reduced 8.78%	800 $288,000
Q4 2020 Feb 10, 2021	BUY	$78.0 - $104.5 $1,638 - $2,194	21 Added 2.45%	877 $324,000
Q3 2020 Nov 16, 2020	SELL	$95.51 - $112.95 $40,496 - $47,890	-424 Reduced 33.13%	856 $353,000
Q2 2020 Aug 07, 2020	SELL	$62.68 - $105.34 $21,185 - $35,604	-338 Reduced 20.89%	1,280 $519,000
Q1 2020 Apr 23, 2020	BUY	$47.79 - $75.63 $955 - $1,512	20 Added 1.25%	1,618 $436,000
Q3 2019 Nov 08, 2019	BUY	$35.53 - $43.8 $56,776 - $69,992	1,598 New	1,598 $238,000

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Counselors Inc with notifications on news.

Account